Finance

Lists
1786:TPE
SciVision Biotech Inc
NT$41.45
+1.10%
(+0.45) 1D
Oct 7, 1:30:18 PM GMT+8  ·   TWD
All symbols
SymbolPriceChange% Change
Generating top insights for 1786...
Open
NT$41.00
High
NT$41.95
Low
NT$41.00
Mkt. cap
3.10B
Avg. vol.
187.47K
Volume
120.47K
Dividend
4.61%
Quarterly dividend
NT$0.48
Ex-dividend date
Jul 24, 2024
P/E ratio
17.99
52-wk high
NT$111.00
52-wk low
NT$40.60
EPS
NT$2.30
Shares outstanding
53.10M
No. of employees
64
Open
NT$41.00
High
NT$41.95
Low
NT$41.00
Mkt. cap
3.10B
Avg. vol.
187.47K
Volume
120.47K
Dividend
4.61%
Quarterly dividend
NT$0.48
Ex-dividend date
Jul 24, 2024
P/E ratio
17.99
52-wk high
NT$111.00
52-wk low
NT$40.60
EPS
NT$2.30
Shares outstanding
53.10M
No. of employees
64
News stories
From web sources and news partners
About SciVision Biotech Inc
CEO-
Employees64
Founded1990
Headquarters-
SectorMedical device
Websitescivision.com.tw
Previous reportsAll values in TWD
Loading Previous Earnings...
Revenue
Net income
All values in TWD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
221.41M
251.39M
205.32M
211.03M
Cost of goods sold
67.33M
62.04M
60.12M
71.98M
Cost of revenue
67.33M
62.04M
60.12M
71.98M
Research and development expenses
21.26M
32.38M
22.94M
20.75M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
86.38M
107.04M
100.96M
89.57M
Operating expense
107.65M
139.42M
123.90M
110.32M
Total operating expenses
174.97M
201.46M
184.02M
182.30M
Operating income
46.44M
49.93M
21.30M
28.73M
Other non operating income
2.10M
2.19M
1.30M
51.00K
EBT including unusual items
71.72M
72.40M
35.68M
27.57M
EBT excluding unusual items
71.72M
74.54M
35.70M
28.60M
Income tax expense
13.39M
9.21M
13.73M
-7.08M
Effective tax rate
18.68%
12.72%
38.47%
-25.67%
Other operating expenses
-
-
-
-
Net income
58.32M
63.18M
21.96M
34.64M
Net profit margin
26.34%
25.13%
10.69%
16.42%
Earnings per share
-
-
-
-
Interest and investment income
4.76M
8.75M
6.50M
7.42M
Interest expense
-2.43M
-3.18M
-3.12M
-3.10M
Net interest expenses
2.34M
5.57M
3.37M
4.32M
Depreciation and amortization charges
-
-
-
-
EBITDA
63.95M
68.84M
41.06M
49.04M
Gain or loss from assets sale
-
10.00K
16.00K
-23.00K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps